EBM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Howden, C. W
Right arrow Search for Related Content
PubMed
Right arrow Articles by Howden, C. W
Evidence-Based Medicine 2003; 8:19
© 2003 BMJ Publishing Group


Therapeutics

Lansoprazole reduced recurrence of ulcer complications in long term use of low dose aspirin

Lai KC, Lam SK, Chu KM, et al.Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.N Engl J Med 2002 ;346:2033–8[Abstract/Free Full Text]

QUESTION: In patients receiving continuous treatment with low dose aspirin, is Helicobacter pylori eradication plus lansoprazole more effective than H pylori eradication alone for preventing the recurrence of ulcer complications?

Key Words: aspirin • omeprazole • peptic ulcer • Helicobacter pylori

The first 150 words of the full text of this article appear below.

Design
Randomised {allocation concealed*}{dagger}, blinded (clinicians, patients, outcome assessors, monitoring committee, and data analysts),* placebo controlled trial with a median follow up of 12 months.

Setting
A university hospital in Hong Kong, China.

Patients
123 patients who were 18–80 years of age (mean age 70 y, 72% men) and had ulcers (gastric, duodenal, or gastroduodenal), were receiving low dose aspirin for >1 month before developing ulcers, had a disease such as stroke or ischaemic heart disease that required long term continuous treatment with low dose aspirin, and had H pylori infection that was objectively diagnosed. Exclusion criteria included oesophagitis; a history of gastric or duodenal surgery other than oversewing of a perforation; allergy to study drugs; H pylori infection that could not be eradicated after 2 attempts with eradication therapies; and concomitant treatment with nonsteroidal anti-inflammatory drugs, corticosteroids, or anticoagulants. Follow up was 92%.

Intervention
After healing of the ulcers and eradication . . . [Full text of this article]

Colin W Howden, MD

Northwestern University Feinberg School of Medicine
Chicago, Illinois, USA







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd.